Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1982 Apr;45(4):491–499. doi: 10.1038/bjc.1982.84

Distribution of T-lymphocyte subsets in Hodgkin's disease characterized by monoclonal antibodies.

M S Dorreen, J A Habeshaw, P F Wrigley, T A Lister
PMCID: PMC2010995  PMID: 6978728

Abstract

Mononuclear-cell suspensions of lymph nodes, spleen and blood from 24 patients with active Hodgkin's disease (HD) were studied for possible imbalance of T and B lymphocytes, and T-lymphocyte subsets, using monospecific anti-T antibodies and other reagents. A profile showing T-cell predominance was demonstrated in lymph nodes and blood, with total T-cells ranging from 50-70% of the cell count. As defined by monoclonal antibodies, 70-85 of the latter comprised the "inducer" subclass, the remainder being "suppressor" cells. There were no essential differences between histologically involved and uninvolved lymph nodes from HD patients, though total T-cell proportions were lower in "normal lymph node" controls. The profiles of spleens electively removed, as part of pre-treatment staging procedures, showed reduced total T-cell numbers, whether these were involved with HD or not. These differences are accounted for principally by fewer T "inducer" cells (24%, in spleen, v. 54% in involved lymph nodes and 47% in "normal" control nodes). Possible explanations for these findings are discussed. Our results demonstrate similar profiles in histologically diseased and normal tissue, rather than any clear imbalance of T-cell proportions which might explain the profound disturbances of T-cell function frequently demonstrated in vivo and in vitro.

Full text

PDF
491

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amlot P. L., Pussell B., Slaney J. M., Williams B. D. Correlation between immune complexes and prognostic factors in Hodgkin's disease. Clin Exp Immunol. 1978 Feb;31(2):166–173. [PMC free article] [PubMed] [Google Scholar]
  2. Bobrove A. M., Fuks Z., Strober S., Kaplan H. S. Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease. Cancer. 1975 Jul;36(1):169–179. doi: 10.1002/1097-0142(197507)36:1<169::aid-cncr2820360115>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  3. Brodsky F. M., Parham P., Barnstable C. J., Crumpton M. J., Bodmer W. F. Monoclonal antibodies for analysis of the HLA system. Immunol Rev. 1979;47:3–61. doi: 10.1111/j.1600-065x.1979.tb00288.x. [DOI] [PubMed] [Google Scholar]
  4. Brown C. A., Hall C. L., Long J. C., Carey K., Weitzman S. A., Aisenberg A. C. Circulating immune complexes in Hodgkin's disease. Am J Med. 1978 Feb;64(2):289–294. doi: 10.1016/0002-9343(78)90058-x. [DOI] [PubMed] [Google Scholar]
  5. Carbone P. P., Kaplan H. S., Musshoff K., Smithers D. W., Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971 Nov;31(11):1860–1861. [PubMed] [Google Scholar]
  6. Dutton R. W. Suppressor T cells. Transplant Rev. 1975;26:39–55. doi: 10.1111/j.1600-065x.1975.tb00174.x. [DOI] [PubMed] [Google Scholar]
  7. Eltringham J. R., Kaplan H. S. Impaired delayed-hypersensitivity responses in 154 patients with untreated Hodgkin's disease. Natl Cancer Inst Monogr. 1973 May;36:107–115. [PubMed] [Google Scholar]
  8. Gupta S., Tan C. Subpopulations of human T lymphocytes. XIV. Abnormality of T-cell locomotion and of distribution of subpopulations of T and B lymphocytes in peripheral blood and spleen from children with untreated Hodgkin's disease. Clin Immunol Immunopathol. 1980 Feb;15(2):133–143. doi: 10.1016/0090-1229(80)90026-4. [DOI] [PubMed] [Google Scholar]
  9. Habeshaw J. A., Catley P. F., Stansfeld A. G., Brearley R. L. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients. Br J Cancer. 1979 Jul;40(1):11–34. doi: 10.1038/bjc.1979.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hoffman R. A., Kung P. C., Hansen W. P., Goldstein G. Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood. Proc Natl Acad Sci U S A. 1980 Aug;77(8):4914–4917. doi: 10.1073/pnas.77.8.4914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hunter C. P., Pinkus G., Woodward L., Moloney W. C., Churchill W. H. Increased T lymphocytes and IgMEA-receptor lymphocytes in Hodgkin's disease spleens. Cell Immunol. 1977 Jun 15;31(2):193–198. doi: 10.1016/0008-8749(77)90020-x. [DOI] [PubMed] [Google Scholar]
  12. Kaur J., Spiers A. S., Catovsky D., Galton D. A. Increase of T lymphocytes in the spleen in Hodgkin's disease. Lancet. 1974 Oct 5;2(7884):800–802. doi: 10.1016/s0140-6736(74)91070-8. [DOI] [PubMed] [Google Scholar]
  13. Kung P., Goldstein G., Reinherz E. L., Schlossman S. F. Monoclonal antibodies defining distinctive human T cell surface antigens. Science. 1979 Oct 19;206(4416):347–349. doi: 10.1126/science.314668. [DOI] [PubMed] [Google Scholar]
  14. Levy R., Kaplan H. S. Impaired lymphocyte function in untreated Hodgkin's disease. N Engl J Med. 1974 Jan 24;290(4):181–186. doi: 10.1056/NEJM197401242900402. [DOI] [PubMed] [Google Scholar]
  15. Lukes R. J., Butler J. J. The pathology and nomenclature of Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1063–1083. [PubMed] [Google Scholar]
  16. Moretta L., Webb S. R., Grossi C. E., Lydyard P. M., Cooper M. D. Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG. J Exp Med. 1977 Jul 1;146(1):184–200. doi: 10.1084/jem.146.1.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Payne S. V., Jones D. B., Haegert D. G., Smith J. L., Wright D. H. T and B lymphocytes and Reed-Sternberg cells in Hodgkin's disease lymph nodes and spleens. Clin Exp Immunol. 1976 May;24(2):280–286. [PMC free article] [PubMed] [Google Scholar]
  18. Poppema S., Bhan A. K., Reinherz E. L., McCluskey R. T., Schlossman S. F. Distribution of T cell subsets in human lymph nodes. J Exp Med. 1981 Jan 1;153(1):30–41. doi: 10.1084/jem.153.1.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Reinherz E. L., Kung P. C., Goldstein G., Schlossman S. F. A monoclonal antibody reactive with the human cytotoxic/suppressor T cell subset previously defined by a heteroantiserum termed TH2. J Immunol. 1980 Mar;124(3):1301–1307. [PubMed] [Google Scholar]
  20. Reinherz E. L., Kung P. C., Goldstein G., Schlossman S. F. A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells. J Immunol. 1979 Sep;123(3):1312–1317. [PubMed] [Google Scholar]
  21. Reinherz E. L., Kung P. C., Goldstein G., Schlossman S. F. Further characterization of the human inducer T cell subset defined by monoclonal antibody. J Immunol. 1979 Dec;123(6):2894–2896. [PubMed] [Google Scholar]
  22. Reinherz E. L., Schlossman S. F. The differentiation and function of human T lymphocytes. Cell. 1980 Apr;19(4):821–827. doi: 10.1016/0092-8674(80)90072-0. [DOI] [PubMed] [Google Scholar]
  23. Romagnani S., Maggi E., Biagiotti R., Giudizi M. G., Amadori A., Ricci M. Altered proportion of T mu-and T gamma-cell subpopulations in patients with Hodgkin's disease. Scand J Immunol. 1978;7(6):511–514. doi: 10.1111/j.1365-3083.1978.tb00485.x. [DOI] [PubMed] [Google Scholar]
  24. Rowley D. A., Fitch F. W., Stuart F. P., Köhler H., Cosenza H. Specific suppression of immune responses. Science. 1973 Sep 21;181(4105):1133–1141. doi: 10.1126/science.181.4105.1133. [DOI] [PubMed] [Google Scholar]
  25. SCHIER W. W., ROTH A., OSTROFF G., SCHRIFT M. H. Hodgkin's disease and immunity. Am J Med. 1956 Jan;20(1):94–99. doi: 10.1016/0002-9343(56)90176-0. [DOI] [PubMed] [Google Scholar]
  26. Sokal J. E. Immunologic deficiency in Hodgkin's disease. Tumori. 1973 Sep-Oct;59(5):343–350. doi: 10.1177/030089167305900506. [DOI] [PubMed] [Google Scholar]
  27. Sousa M. D., Yang M., Lopes-Corrales E., Tan C., Hansen J. A., Dupont B., Good R. A. Ecotaxis: the principle and its application to the study of Hodgkin's disease. Clin Exp Immunol. 1977 Jan;27(1):143–151. [PMC free article] [PubMed] [Google Scholar]
  28. Wagener D. J., Van Munster P. J., Haanen C. The immunoglobulins in Hodgkin's disease. Eur J Cancer. 1976 Sep;12(9):683–688. doi: 10.1016/0014-2964(76)90016-5. [DOI] [PubMed] [Google Scholar]
  29. Webb D. R., Jr, Jamieson T. Control of mitogen-induced transformation: characterization of a splenic suppressor cell and its mode of action. Cell Immunol. 1976 Jun 1;24(1):45–57. doi: 10.1016/0008-8749(76)90130-1. [DOI] [PubMed] [Google Scholar]
  30. Young R. C., Corder M. P., Berard C. W., DeVita V. T. Immune alterations in Hodgkin's disease. Effect of delayed hypersensitivity and lymphocyte transformation on course and survival. Arch Intern Med. 1973 Mar;131(3):446–454. doi: 10.1001/archinte.131.3.446. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES